Recent machine-extracted executive movements from SEC 8-K Item 5.02 filings, source-linked. Every card cites the SEC source.
Showing 9101–9150 of 18437
On the Effective Date, Mr. Knop will succeed David M. Khani, who has been serving as the Company’s CFO during a previously announced period of transition and who will remain employed with the Company to provide certain transition services until July 31, 2023.
On July 19, 2023, the Board of Directors (the “Board”) of EQT Corporation (the “Company”) elected Jeremy T. Knop as Chief Financial Officer (“CFO”) of the Company, effective on July 24, 2023 (the “Effective Date”).
On July 17, 2023, TechPrecision Corporation (the “ Company ”) entered into an Employment Agreement with Barbara M. Lilley (the “ Employment Agreement ”), with an effective date as of July 14, 2023 and which governs Ms. Lilley’s employment as Chief Financial Officer of the Company.
The Company has appointed Ryan Blust, the Company’s Vice President, Finance, as its interim Chief Financial Officer, effective immediately.
On July 21, 2023, Trulieve Cannabis Corp. (the “Company”) announced the departure of Tim Mullany as Chief Financial Officer, for personal reasons and effective July 20, 2023.
Todd F. Clossin will retire from his position as President and Chief Executive Officer of the Company effective August 1, 2023
Jeffrey H. Jackson, previously the Company’s Senior Executive Vice President and Chief Operating Officer, has been appointed to serve as the Company’s President and Chief Executive Officer as of August 1, 2023.
Margaret Gezerlis agreed that Ms. Gezerlis would step down as Executive Vice President and Chief Financial Officer
On July 20, 2023, CPS Technologies Corp. (the Company”) issued a press release announcing that it has appointed Brian Mackey, 53, as President and Chief Executive Officer of the Company, effective as of August 14, 2023.
Effective July 15, 2023, Kevin Williams resigned as the Chief Financial Officer of the Company and Jin Kuang was appointed to fill the resulting vacancy.
Jin Kuang was appointed to fill the resulting vacancy.
On July 20, 2023, Matthew Hidalgo resigned as Chief Financial Officer of Vision Energy Corporation (the "Company") effective immediately.
On July 20, 2023, the Board of Directors of InspireMD, Inc. (the “Company”) appointed Amir Kohen, the Company’s Vice President of Finance and Human Resources, to serve as of interim Chief Financial Officer, Secretary and Treasurer during the time that Craig Shore is out on medical leave.
As previously announced, Andrew A. Wiederhorn resigned as Chief Executive Officer of FAT Brands Inc. (the “ Company ”) effective as of May 5, 2023
the Board appointed Seth Kaufman, age 49, as the Company’s President and Chief Executive Officer, effective on or prior to October 30, 2023.
Simona King, the Company’s Chief Financial Officer, and Alex Fotopoulos, the Company’s Chief Technical Officer, will separate from the Company, effective on or about July 28, 2023.
On July 15, 2023, Kathleen Borthwick, the current Vice President, Finance of the Company was appointed to serve as Senior Vice President and Interim Chief Financial Officer, effective on or about July 28, 2023.
the following persons no longer hold a position as an officer of the Company: Mr. Batarseh as President and Chief Executive Officer and Mr. Skidmore as Chief Financial Officer and Treasurer
the following persons no longer hold a position as an officer of the Company: Mr. Batarseh as President and Chief Executive Officer and Mr. Skidmore as Chief Financial Officer and Treasurer
Patrick Holt was appointed to the role of President and Chief Executive Officer (and principal executive officer) of Amarin, effective July 18, 2023
On July 20, 2023, Energous Corporation (the “Company”) announced that William Mannina has resigned from his position as the Company’s Interim Chief Financial Officer, effective August 16, 2023.
Name Age Position(s) Rajiv Shukla 48 Executive Chairman Randolph W. Hubbell 60 Chief Executive Officer, President and Director James Hart, M.D. 71 Chief Medical Officer Donna Godward 68 Chief Quality Officer Janet Vargo, Ph.D. 65 Vice President Clinical Services
James Clavijo, who has been serving as interim CFO on a consulting basis while the Company searched for a permanent CFO, will step down from that interim position as of July 31, 2023
On July 14, 2023, Roger Cockroft’s employment with and service as Chief Executive Officer of Fresh Vine Wine, Inc. (the “Company”) ended.
On July 19, 2023, the Company’s Board of Directors appointed Keith J. Johnson to serve as Interim Chief Financial Officer of the Company.
On July 19, 2023, the Company’s Board of Directors appointed Michael Pruitt, the Non-Executive Chair of the Company’s Board of Directors, to serve as Interim Chief Executive Officer, effective immediately.
On July 14, 2023, Hitesh Dheri’s employment with and service as Chief Financial Officer and Secretary the Company ended.
On July 14, 2023, Atul Varma and Hamilton Lane Incorporated (the “Company”) reached mutual agreement that Mr. Varma will resign from his position as Chief Financial Officer and Treasurer of the Company, effective August 8, 2023.
On the same day and in connection with Mr. Varma’s resignation, the Company appointed Jeffrey Armbrister as Chief Financial Officer and Treasurer, also effective as of August 8, 2023.
On July 14, 2023, the board of directors (the “Board of Directors”) of Lottery.com, Inc. (the “Company”) appointed Robert J. Stubblefield as Chief Financial Officer of the Company, effective immediately.
and appointed Matthew McGahan, the Chairman of the Board of Directors, to serve as interim Chief Executive Officer
On July 20, 2023, the Board of Directors terminated Mark Gustavson from his role as Chief Executive Officer of the Company
Skye Fossey-Tomaske, who has been serving as the Company’s Interim Chief Financial Officer in addition to her role as Corporate Controller of the Company, will step down from her role as the Interim Chief Financial Officer upon the effectiveness of Mr. Sanchez’s appointment.
On July 17, 2023, Mobivity Holdings Corp. (the “Company”) announced that William T. Sanchez was appointed to serve as the Chief Financial Officer of the Company, effective as of July 17, 2023.
In connection with Kim Dang’s previously announced appointment as Chief Executive Officer (“CEO”) of Kinder Morgan, Inc. (“KMI”) as of August 1, 2023
On July 14, 2023, Lora L. Daves, Chief Financial Officer of Southern Missouri Bancorp, Inc. (the “Company”) and its wholly-owned subsidiary, Southern Bank (the “Bank”), informed the Company and the Bank that she was resigning her employment effective August 4, 2023, to pursue other interests.
Upon the effectiveness of Ms. Daves’ resignation, Matthew T. Funke, who is the Company’s President and Chief Administrative Officer (and principal financial officer) and served as its Chief Financial Officer (and principal financial and accounting officer) from 2006 until 2022, has been appointed to serve as Interim Chief Financial Officer (and principal financial and accounting officer) of the Company.
the Board of Directors of the Company (the “Board”) appointed Kimberly Benson as interim Chief Financial Officer and interim principal accounting officer of the Company, effective as of July 19, 2023.
Karen Diepholz, the Company’s Chief Financial Officer and principal accounting officer, resigned from her position with the Company on July 19, 2023, effective immediately.
On July 20, 2023, the Board of Directors of the Company (the “Board”) approved the appointment of Stacy Bowman as the Company’s CFO and principal financial officer on an interim basis, effective as of July 29, 2023.
On July 17, 2023, Mr. Marte notified the Company of his decision to retire from his position effective as of July 28, 2023.
appointed Mary Hoitt as interim Chief Financial Officer (“CFO”), effective as of July 17, 2023
Kyle Wismans will assume the role of chief financial officer of XPO, Inc. (the “Company”) on August 11, 2023.
On July 14, 2023, Armata Pharmaceuticals, Inc. (the “Company”) and Dr. Brian Varnum, the Company’s former Chief Executive Officer, entered into a separation and release agreement
Mr. D’Amico will serve as the Company’s Chief Financial Officer, effective as of August 7, 2023.
On July 13, 2023 James Frinzi tendered his resignation in writing as Chief Executive Officer of the Company.
The board of directors of Astra CA appointed Kermit Harris (currently a director and President of the Company), as Chief Executive Officer and as a director
Effective as of July 10, 2023, MusclePharm Corporation (the “Company”) terminated Chief Financial Officer, Gary Shirshac.
As of this filing, Anthony Todaro has been named as the Company’s interim Chief Financial Officer.
the Company mutually agreed that Mr. Lannon would resign from such positions.
Recent executive movements from 8-K Item 5.02 filings, source-linked. Cards are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.